Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | |
| Cash Flows From Operating Activities | |
| Net Income | -50,312 |
| Depreciation Amortization | 6,274 |
| Accounts receivable | -18 |
| Accounts payable and accrued liabilities | 539 |
| Other Working Capital | -41 |
| Other Operating Activity | 3,185 |
| Operating Cash Flow | $-40,373 |
| Cash Flows From Investing Activities | |
| PPE Investments | -255 |
| Investing Cash Flow | $-255 |
| Cash Flows From Financing Activities | |
| Debt Repayment | -1,107 |
| Common Stock Issued | 235 |
| Other Financing Activity | 3,251 |
| Financing Cash Flow | $2,379 |
| Beginning Cash Position | 93,713 |
| End Cash Position | 55,464 |
| Net Cash Flow | $-38,249 |
| Free Cash Flow | |
| Operating Cash Flow | -40,373 |
| Capital Expenditure | -305 |
| Free Cash Flow | -40,678 |